Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Audinot, V; Newman-Tancredi, A; Cussac, D; Millan, MJ
   Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors
   NEUROPSYCHOPHARMACOLOGY
   
   V. Audinot et al., "Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT1D receptors", NEUROPSYCH, 25(3), 2001, pp. 410-422
2. Millan, MJ; Cussac, D; Milligan, G; Carr, C; Audinot, V; Gobert, A; Lejeune, F; Rivet, JM; Brocco, M; Duqueyroix, D; Nicolas, JP; Boutin, JA; Newman-Tancredi, A
   Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization
   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
   
   M.J. Millan et al., "Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization", J PHARM EXP, 297(3), 2001, pp. 876-887
3. Millan, MJ; Newman-Tancredi, A; Duqueyroix, D; Cussac, D
   Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   M.J. Millan et al., "Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase", EUR J PHARM, 424(1), 2001, pp. 13-17
4. Cussac, D; Schaak, S; Denis, C; Flordellis, C; Calise, D; Paris, H
   High level of alpha 2-adrenoceptor in rat foetal liver and placenta is dueto alpha 2B-subtype expression in haematopoietic cells of the erythrocyte lineage
   BRITISH JOURNAL OF PHARMACOLOGY
   
   D. Cussac et al., "High level of alpha 2-adrenoceptor in rat foetal liver and placenta is dueto alpha 2B-subtype expression in haematopoietic cells of the erythrocyte lineage", BR J PHARM, 133(8), 2001, pp. 1387-1395
5. Millan, MJ; Newman-Tancredi, A; Quentric, Y; Cussac, D
   The '' selective '' dopamine D-1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin(2C) receptors
   PSYCHOPHARMACOLOGY
   
   M.J. Millan et al., "The '' selective '' dopamine D-1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin(2C) receptors", PSYCHOPHAR, 156(1), 2001, pp. 58-62
6. Millan, MJ; Gobert, A; Rivet, JM; Adhumeau-Auclair, A; Cussac, D; Newman-Tancredi, A; Dekeyne, A; Nicolas, JP; Lejeune, F
   Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram
   EUROPEAN JOURNAL OF NEUROSCIENCE
   
   M.J. Millan et al., "Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram", EUR J NEURO, 12(3), 2000, pp. 1079-1095
7. Millan, MJ; Newman-Tancredi, A; Audinot, V; Cussac, D; Lejeune, F; Nicolas, JP; Coge, F; Galizzi, JP; Boutin, JA; Rivet, JM; Dekeyne, A; Gobert, A
   Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states
   SYNAPSE
   
   M.J. Millan et al., "Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT1B, 5-HT1D and dopamine D-2 and D-3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states", SYNAPSE, 35(2), 2000, pp. 79-95
8. Cussac, D; Newman-Tancredi, A; Nicolas, JP; Boutin, JA; Millan, MJ
   Antagonist properties of the novel antipsychotic, S16924, at cloned, humanserotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol
   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
   
   D. Cussac et al., "Antagonist properties of the novel antipsychotic, S16924, at cloned, humanserotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol", N-S ARCH PH, 361(5), 2000, pp. 549-554
9. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
   [H-3]S33084: a novel, selective and potent radioligand at cloned, human dopamine D-3 receptors
   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
   
   D. Cussac et al., "[H-3]S33084: a novel, selective and potent radioligand at cloned, human dopamine D-3 receptors", N-S ARCH PH, 361(5), 2000, pp. 569-572
10. Cussac, D; Newman-Tancredi, A; Quentric, Y; Millan, MJ
    An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [H-3]phosphatidylinositol depletion
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    D. Cussac et al., "An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [H-3]phosphatidylinositol depletion", N-S ARCH PH, 361(2), 2000, pp. 221-223
11. Schaak, S; Cayla, C; Lymperopoulos, A; Flordellis, C; Cussac, D; Denis, C; Paris, H
    Transcriptional down-regulation of the human alpha 2C-Adrenergic receptor by cAMP
    MOLECULAR PHARMACOLOGY
    
    S. Schaak et al., "Transcriptional down-regulation of the human alpha 2C-Adrenergic receptor by cAMP", MOLEC PHARM, 58(4), 2000, pp. 821-827
12. Millan, MJ; Dekeyne, A; Newman-Tancredi, A; Cussac, D; Audinot, V; Milligan, G; Duqueyroix, D; Girardon, S; Mullot, J; Boutin, JA; Nicolas, JP; Renouard-Try, A; Lacoste, JM; Cordi, A
    S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine", J PHARM EXP, 295(3), 2000, pp. 1192-1205
13. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
    S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626", J PHARM EXP, 293(3), 2000, pp. 1048-1062
14. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
    S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile", J PHARM EXP, 292(1), 2000, pp. 38-53
15. Schaak, S; Cussac, D; Cayla, C; Devedjian, JC; Guyot, R; Paris, H; Denis, C
    Alpha(2) adrenoceptors regulate proliferation of human intestinal epithelial cells
    GUT
    
    S. Schaak et al., "Alpha(2) adrenoceptors regulate proliferation of human intestinal epithelial cells", GUT, 47(2), 2000, pp. 242-250
16. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
    The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    D. Cussac et al., "The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors", EUR J PHARM, 394(1), 2000, pp. 47-50
17. Dubuffet, T; Newman-Tancredi, A; Cussac, D; Audinot, V; Loutz, A; Millan, MJ; Lavielle, G
    Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    T. Dubuffet et al., "Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D-3 receptor antagonists", BIOORG MED, 9(14), 1999, pp. 2059-2064
18. Cussac, D; Vidal, M; Leprince, C; Liu, WQ; Tiraboschi, G; Roques, BP; Garbay, C
    A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity
    FASEB JOURNAL
    
    D. Cussac et al., "A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity", FASEB J, 13(1), 1999, pp. 31-39
19. Boudon-Cussac, D; Hild, F; Pijaudier-Cabot, G
    Tensile damage in concrete: Analysis of experimental technique
    JOURNAL OF ENGINEERING MECHANICS-ASCE
    
    D. Boudon-Cussac et al., "Tensile damage in concrete: Analysis of experimental technique", J ENG MEC, 125(8), 1999, pp. 906-913
20. Newman-Tancredi, A; Cussac, D; Audinot, V; Millan, MJ
    Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    A. Newman-Tancredi et al., "Actions of roxindole at recombinant human dopamine D-2, D-3 and D-4 and serotonim 5-HT1A, 5-HT1B and 5-HT1D receptors", N-S ARCH PH, 359(6), 1999, pp. 447-453
21. Cussac, D; Newman-Tancredi, A; Pasteau, V; Millan, MJ
    Human dopamine D-3 receptors mediate mitogen- activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism
    MOLECULAR PHARMACOLOGY
    
    D. Cussac et al., "Human dopamine D-3 receptors mediate mitogen- activated protein kinase activation via a phosphatidylinositol 3-kinase and an atypical protein kinase C-dependent mechanism", MOLEC PHARM, 56(5), 1999, pp. 1025-1030
22. Newman-Tancredi, A; Cussac, D; Audinot, V; Pasteau, V; Gavaudan, S; Millan, MJ
    G protein activation by human dopamine D-3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5 '-O-(3-[S-35]thio)-triphosphate binding and antibody study
    MOLECULAR PHARMACOLOGY
    
    A. Newman-Tancredi et al., "G protein activation by human dopamine D-3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5 '-O-(3-[S-35]thio)-triphosphate binding and antibody study", MOLEC PHARM, 55(3), 1999, pp. 564-574
23. Vidal, M; Goudreau, N; Cornille, F; Cussac, D; Gincel, E; Garbay, C
    Molecular and cellular analysis of Grb2 SH3 domain mutants: Interaction with Sos and dynamin
    JOURNAL OF MOLECULAR BIOLOGY
    
    M. Vidal et al., "Molecular and cellular analysis of Grb2 SH3 domain mutants: Interaction with Sos and dynamin", J MOL BIOL, 290(3), 1999, pp. 717-730
24. CUSSAC D; DENISPOUXVIEL C; CALISE D; PARIS H
    HIGH-LEVEL OF ALPHA-2-ADRENOCEPTOR IN FETAL-RAT LIVER IS DUE TO ALPHA-2B-SUBTYPE EXPRESSION IN HEMATOPOIETIC-CELLS
    Naunyn-Schmiedeberg's archives of pharmacology
    
    D. Cussac et al., "HIGH-LEVEL OF ALPHA-2-ADRENOCEPTOR IN FETAL-RAT LIVER IS DUE TO ALPHA-2B-SUBTYPE EXPRESSION IN HEMATOPOIETIC-CELLS", Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4210-4210
25. MILLAN MJ; GOBERT A; NEWMANTANCREDI A; AUDINOT V; LEJEUNE F; RIVET JM; CUSSAC D; NICOLAS JP; MULLER O; LAVIELLE G
    S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL
    The Journal of pharmacology and experimental therapeutics
    
    M.J. Millan et al., "S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - I - RECEPTORIAL AND NEUROCHEMICAL PROFILE COMPARISON WITH CLOZAPINE AND HALOPERIDOL", The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1341-1355
26. VIDAL M; MONTIEL JL; CUSSAC D; CORNILLE F; DUCHESNE M; PARKER F; TOCQUE B; ROQUES BP; GARBAY C
    DIFFERENTIAL INTERACTIONS OF THE GROWTH-FACTOR RECEPTOR-BOUND PROTEIN-A N-SH3 DOMAIN WITH SON OF SEVENLESS AND DYNAMIN - POTENTIAL ROLE IN THE RAS-DEPENDENT SIGNALING PATHWAY
    The Journal of biological chemistry
    
    M. Vidal et al., "DIFFERENTIAL INTERACTIONS OF THE GROWTH-FACTOR RECEPTOR-BOUND PROTEIN-A N-SH3 DOMAIN WITH SON OF SEVENLESS AND DYNAMIN - POTENTIAL ROLE IN THE RAS-DEPENDENT SIGNALING PATHWAY", The Journal of biological chemistry, 273(9), 1998, pp. 5343-5348
27. LEPRINCE C; ROMERO F; CUSSAC D; VAYSSIERE B; BERGER R; TAVITIAN A; CAMONIS J
    A NEW MEMBER OF THE AMPHIPHYSIN FAMILY CONNECTING ENDOCYTOSIS AND SIGNAL-TRANSDUCTION PATHWAYS
    The FASEB journal
    
    C. Leprince et al., "A NEW MEMBER OF THE AMPHIPHYSIN FAMILY CONNECTING ENDOCYTOSIS AND SIGNAL-TRANSDUCTION PATHWAYS", The FASEB journal, 11(9), 1997, pp. 415-415
28. CORNILLE F; MARTIN L; LENOIR C; CUSSAC D; ROQUES BP; FOURNIEZALUSKI MC
    COOPERATIVE EXOSITE-DEPENDENT CLEAVAGE OF SYNAPTOBREVIN BY TETANUS TOXIN LIGHT-CHAIN
    The Journal of biological chemistry
    
    F. Cornille et al., "COOPERATIVE EXOSITE-DEPENDENT CLEAVAGE OF SYNAPTOBREVIN BY TETANUS TOXIN LIGHT-CHAIN", The Journal of biological chemistry, 272(6), 1997, pp. 3459-3464
29. LEPRINCE C; ROMERO F; CUSSAC D; VAYSSIERE B; BERGER R; TAVITIAN A; CAMONIS JH
    A NEW MEMBER OF THE AMPHIPHYSIN FAMILY CONNECTING ENDOCYTOSIS AND SIGNAL-TRANSDUCTION PATHWAYS
    The Journal of biological chemistry
    
    C. Leprince et al., "A NEW MEMBER OF THE AMPHIPHYSIN FAMILY CONNECTING ENDOCYTOSIS AND SIGNAL-TRANSDUCTION PATHWAYS", The Journal of biological chemistry, 272(24), 1997, pp. 15101-15105
30. GUICHARD S; CUSSAC D; HENNEBELLE I; BUGAT R; CANAL P
    SEQUENCE-DEPENDENT ACTIVITY OF THE IRINOTECAN-5FU COMBINATION IN HUMAN COLON-CANCER MODEL HT-29 IN-VITRO AND IN-VIVO
    International journal of cancer
    
    S. Guichard et al., "SEQUENCE-DEPENDENT ACTIVITY OF THE IRINOTECAN-5FU COMBINATION IN HUMAN COLON-CANCER MODEL HT-29 IN-VITRO AND IN-VIVO", International journal of cancer, 73(5), 1997, pp. 729-734
31. CUSSAC D; KORDON C; ENJALBERT A; SALTARELLI D
    ADP-RIBOSYLATION OF G-ALPHA-I AND G-ALPHA-O IN PITUITARY-CELLS ENHANCES THEIR RECOGNITION BY ANTIBODIES DIRECTED AGAINST THEIR CARBOXYL TERMINI
    Journal of receptor and signal transduction research
    
    D. Cussac et al., "ADP-RIBOSYLATION OF G-ALPHA-I AND G-ALPHA-O IN PITUITARY-CELLS ENHANCES THEIR RECOGNITION BY ANTIBODIES DIRECTED AGAINST THEIR CARBOXYL TERMINI", Journal of receptor and signal transduction research, 16(3-4), 1996, pp. 169-190
32. CUSSAC D; LEBLANC P; LHERITIER A; BERTOGLIO J; LANG P; KORDON C; ENJALBERT A; SALTARELLI D
    RHO-PROTEIN ARE LOCALIZED WITH DIFFERENT MEMBRANE COMPARTMENTS INVOLVED IN VESICULAR TRAFFICKING IN ANTERIOR-PITUITARY-CELLS
    Molecular and cellular endocrinology
    
    D. Cussac et al., "RHO-PROTEIN ARE LOCALIZED WITH DIFFERENT MEMBRANE COMPARTMENTS INVOLVED IN VESICULAR TRAFFICKING IN ANTERIOR-PITUITARY-CELLS", Molecular and cellular endocrinology, 119(2), 1996, pp. 195-206
33. POPOFF MR; CHAVESOLARTE E; LEMICHEZ E; VONEICHELSTREIBER C; THELESTAM M; CHARDIN P; CUSSAC D; ANTONNY B; CHAVRIER P; FLATAU G; GIRY M; DEGUNZBURG J; BOQUET P
    RAS, RAP, AND RAC SMALL GTP-BINDING PROTEINS ARE TARGETS FOR CLOSTRIDIUM-SORDELLII LETHAL TOXIN GLUCOSYLATION
    The Journal of biological chemistry
    
    M.R. Popoff et al., "RAS, RAP, AND RAC SMALL GTP-BINDING PROTEINS ARE TARGETS FOR CLOSTRIDIUM-SORDELLII LETHAL TOXIN GLUCOSYLATION", The Journal of biological chemistry, 271(17), 1996, pp. 10217-10224
34. CHARDIN P; CUSSAC D; MAIGNAN SB; DUCRUIX A
    THE GRB2 ADAPTER
    FEBS letters
    
    P. Chardin et al., "THE GRB2 ADAPTER", FEBS letters, 369(1), 1995, pp. 47-51
35. CUSSAC D; FRECH M; CHARDIN P
    BINDING OF THE GRB2 SH2 DOMAIN TO PHOSPHOTYROSINE MOTIFS DOES NOT CHANGE THE AFFINITY OF ITS SH3 DOMAINS FOR SOS PROLINE-RICH MOTIFS
    EMBO journal
    
    D. Cussac et al., "BINDING OF THE GRB2 SH2 DOMAIN TO PHOSPHOTYROSINE MOTIFS DOES NOT CHANGE THE AFFINITY OF ITS SH3 DOMAINS FOR SOS PROLINE-RICH MOTIFS", EMBO journal, 13(17), 1994, pp. 4011-4021
36. CUSSAC D; CACCAVELLI L; PELLEGRINI I; AUDINOT V; JAQUET P; ENJALBERT A
    MEMBRANE-RECEPTORS AND G-PROTEINS IN ANTE RIOR-PITUITARY-CELLS
    Comptes rendus des seances de la Societe de biologie et de ses filiales
    
    D. Cussac et al., "MEMBRANE-RECEPTORS AND G-PROTEINS IN ANTE RIOR-PITUITARY-CELLS", Comptes rendus des seances de la Societe de biologie et de ses filiales, 187(1), 1993, pp. 14-23
37. CACCAVELLI L; CUSSAC D; PELLEGRINI I; AUDINOT V; JAQUET P; ENJALBERT A
    D2 DOPAMINERGIC RECEPTORS - NORMAL AND ABNORMAL TRANSDUCTION MECHANISMS
    Hormone research
    
    L. Caccavelli et al., "D2 DOPAMINERGIC RECEPTORS - NORMAL AND ABNORMAL TRANSDUCTION MECHANISMS", Hormone research, 38(1-2), 1992, pp. 78-83